Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
2,685
+150
+6% +$17.6K 0.29% 75
2026
Q1
$305K Buy
2,535
+784
+45% +$90.5K 0.31% 78
2025
Q4
$184K Buy
+1,751
New +$164K 0.18% 113

Other funds holding MRK

Entelevest's MRK Position: Q2 2026 in Review

Entelevest increased its Merck (MRK) stake by 5.9% in Q2 2026, buying an estimated $17.6K and bringing the position to 2,685 shares worth $345K. The position accounts for 0.29% of the portfolio, ranked #75.

Entelevest first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Entelevest held 2,685 shares of Merck worth $345K as of Q2 2026.
  • Entelevest bought 150 Merck shares in Q2 2026, an estimated $17.6K.
  • Merck made up 0.29% of Entelevest's portfolio in Q2 2026, its #75 holding.
  • Entelevest first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Entelevest's 13F filing for Q2 2026, filed 22 Jul 2026.